Ganoderma Lucidum (Reishi) Powder
Natural health product licensed in Canada
- Licence holder
- Yi Jia International Group(Canada) Ltd
- NPN or DIN-HM
- 80085196
- Status
- Active licence
- Licence date
- 14 May 2018
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Ganoderma lucidum Source : Corps fructifère | 600 milligramme | Not calculated |
Non-medicinal ingredients
Extrait de fleur/feuille/tige d'Echinacea purpurea
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 2 Capsule | 3 Tous les jours |
Uses authorised in Canada
Source of/Provides antioxidants. Source of fungal polysaccharides with immunomodulating properties. Used in Herbal Medicine to support the immune system. Used in Herbal Medicine as an adaptogen to help increase energy and resistance to stress.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Hypersensitivity/allergy can occur; in which case, discontinue use.
Source
Official Health Canada record, licence 80085196
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.